Lakefront Biotherapeutics N.V.
LKFT | NASDAQ
$32.28
-$0.05 (-0.15%)
At close: Oct 30, 2026, 4:00 PM ET
$32.31
+$0.03 (+0.09%)
Pre-market:
Nov 2, 2026, 7:57 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Cash & Equivalents | 87.87M |
Short-Term Investments | 2.91B |
Long-Term Investments | 46.81M |
Other Long-Term Assets | 198.55M |
Receivables | 53.2M |
Inventory | 22.49M |
Other Current Assets | 5.61M |
Total Current Assets | 3.08B |
Property-Plant & Equipment | 80.66M |
Goodwill & Intangibles | 848K |
Total Long-Term Assets | 327.06M |
Total Assets | 3.41B |
Account Payables | 32.62M |
Deferred Revenue | 32K |
Short-Term Debt | n/a |
Other Current Liabilities | 117.51M |
Total Current Liabilities | 152.86M |
Long-Term Debt | n/a |
Other Long-Term Liabilities | 12.6M |
Total Long-Term Liabilities | 17.79M |
Total Liabilities | 170.65M |
Total Debt | 6.92M |
Book Value | 3.24B |
Book Value Per Share | 49.10 |
Common Stock | 293.94M |
Retained Earnings | 210.58M |
Comprehensive Income | -5.64M |
Shareholders Equity | 3.24B |
Total Investments | 2.96B |
Add to Watchlist
Select watchlists to add or remove LKFT